Search
for
Sort by
Research 601–630 of 1000+
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Androgenic disorders
- Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature
- Idiopathic Hirsutism*
- Needle mesotherapy in adjunctive treatment of Androgenic Alopecia
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Smart Diagnostic System for Health Risk Assessment
- Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi Study
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Safety of testosterone use in women
- Licorice: A review on phytochemical insights and therapeutic potential
- Serum irisin level in patients with acne vulgaris
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- The dermatological consequences of obesity
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- The Associations of Androgen-Related Genes CYP21A2 and CYP19A1 with Severe Acne Vulgaris in Patients from Southwest China
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data
- Male polycystic ovarian syndrome phenotype: a meta-analysis of endocrine-metabolic dysregulation in fathers and brothers of PCOS-affected women
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne